Authors:
MCDERMOTT DF
TREHU EG
MIER JW
SORCE D
RAND W
RONAYNE L
KAPPLER K
CLANCY M
KLEMPNER M
ATKINS MB
Citation: Df. Mcdermott et al., A 2-PART PHASE-I TRIAL OF HIGH-DOSE INTERLEUKIN-2 IN COMBINATION WITHSOLUBLE (CHINESE-HAMSTER OVARY) INTERLEUKIN-1 RECEPTOR, Clinical cancer research, 4(5), 1998, pp. 1203-1213
Authors:
MCDERMOTT DF
TREHU EG
MIER JW
SORCE D
RAND W
RONAYNE L
KAPPLER K
CLANCY M
KLEMPNER M
ATKINS MB
Citation: Df. Mcdermott et al., A 2-PART PHASE-I TRIAL OF HIGH-DOSE INTERLEUKIN-2 IN COMBINATION WITHSOLUBLE (CHINESE-HAMSTER OVARY) INTERLEUKIN-1 RECEPTOR, Clinical cancer research, 4(5), 1998, pp. 1203-1213
Authors:
POTTER DA
TIRNAUER JS
JANSSEN R
CROALL DE
HUGHES CN
FIACCO KA
MIER JW
MAKI M
HERMAN IM
Citation: Da. Potter et al., CALPAIN REGULATED ACTIN REMODELING DURING CELL SPREADING (VOL 141, PG647, 1998), The Journal of cell biology, 141(5), 1998, pp. 1289-1289
Authors:
JANSSEN RAJ
VEENSTRA KG
JONASCH P
JONASCH E
MIER JW
Citation: Raj. Janssen et al., RAS-INDUCED AND RAF-INDUCED DOWN-MODULATION OF NONMUSCLE TROPOMYOSIN ARE MEK-INDEPENDENT, The Journal of biological chemistry, 273(48), 1998, pp. 32182-32186
Authors:
ATKINS MB
ROBERTSON MJ
GORDON M
LOTZE MT
DECOSTE M
DUBOIS JS
RITZ J
SANDLER AB
EDINGTON HD
GARZONE PD
MIER JW
CANNING CM
BATTIATO L
TAHARA H
SHERMAN ML
Citation: Mb. Atkins et al., PHASE-I EVALUATION OF INTRAVENOUS RECOMBINANT HUMAN INTERLEUKIN-12 INPATIENTS WITH ADVANCED MALIGNANCIES, Clinical cancer research, 3(3), 1997, pp. 409-417
Citation: Raj. Janssen et Jw. Mier, TROPOMYOSIN-2 CDNA LACKING THE 3'-UNTRANSLATED REGION RIBOREGULATOR INDUCES GROWTH-INHIBITION OF V-KI-RAS-TRANSFORMED FIBROBLASTS, Molecular biology of the cell, 8(5), 1997, pp. 897-908
Authors:
DUBOIS JS
TREHU EG
MIER JW
SHAPIRO L
EPSTEIN M
KLEMPNER M
DINARELLO C
KAPPLER K
RONAYNE L
RAND W
ATKINS MB
Citation: Js. Dubois et al., RANDOMIZED PLACEBO-CONTROLLED CLINICAL-TRIAL OF HIGH-DOSE INTERLEUKIN-2 IN COMBINATION WITH A SOLUBLE P75 TUMOR-NECROSIS-FACTOR RECEPTOR IMMUNOGLOBULIN-G CHIMERA IN PATIENTS WITH ADVANCED MELANOMA AND RENAL-CELL CARCINOMA, Journal of clinical oncology, 15(3), 1997, pp. 1052-1062
Authors:
TREHU EG
MIER JW
DUBOIS JS
SORCE D
KLEMPNER MS
EPSTEIN M
DINARELLO CA
SHAPIRO L
KAPPLER K
RONAYNE L
ATKINS MB
Citation: Eg. Trehu et al., PHASE-I TRIAL OF INTERLEUKIN-2 IN COMBINATION WITH THE SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTOR P75 IGG CHIMERA, Clinical cancer research, 2(8), 1996, pp. 1341-1351
Citation: Ma. Sikorski et al., L-SELECTIN CROSS-LINKING INDUCES INTEGRIN-DEPENDENT ADHESION - EVIDENCE FOR A SIGNALING PATHWAY INVOLVING PTK BUT NOT PKC, Cell adhesion and communication, 4(4-5), 1996, pp. 355-367
Authors:
STODDART JH
JASUJA RR
SIKORSKI MA
VONANDRIAN UH
MIER JW
Citation: Jh. Stoddart et al., PROTEASE-RESISTANT L-SELECTIN MUTANTS - DOWN-MODULATION BY CROSS-LINKING BUT NOT CELLULAR ACTIVATION, The Journal of immunology, 157(12), 1996, pp. 5653-5659
Citation: H. Tilg et al., INDUCTION OF CIRCULATING INTERLEUKIN-10 BY INTERLEUKIN-1 AND INTERLEUKIN-2, BUT NOT INTERLEUKIN-6 IMMUNOTHERAPY, Cytokine, 7(7), 1995, pp. 734-739
Authors:
RYAN CM
ATKINS MB
MIER JW
GELFAND JA
TOMPKINS RG
Citation: Cm. Ryan et al., EFFECTS OF MALIGNANCY AND INTERLEUKIN-2 INFUSION ON GUT MACROMOLECULAR PERMEABILITY, Critical care medicine, 23(11), 1995, pp. 1801-1806
Authors:
SPARANO JA
FISHER RI
WEISS GR
MARGOLIN K
ARONSON FR
HAWKINS MJ
ATKINS MB
DUTCHER JP
GAYNOR ER
BOLDT DH
DOROSHOW JH
ERNEST ML
SZNOL M
MIER JW
Citation: Ja. Sparano et al., PHASE-II TRIALS OF HIGH-DOSE INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS IN ADVANCED BREAST-CARCINOMA AND CARCINOMA OF THE LUNG, OVARY, AND PANCREAS AND OTHER TUMORS, Journal of immunotherapy with emphasis on tumor immunology, 16(3), 1994, pp. 216-223
Authors:
MARGOLIN K
ARONSON FR
SZNOL M
ATKINS MB
GUCALP R
FISHER RI
SUNDERLAND M
DOROSHOW JH
ERNEST ML
MIER JW
DUTCHER JP
GAYNOR ER
WEISS GR
Citation: K. Margolin et al., PHASE-II STUDIES OF RECOMBINANT HUMAN INTERLEUKIN-4 IN ADVANCED RENAL-CANCER AND MALIGNANT-MELANOMA, Journal of immunotherapy with emphasis on tumor immunology, 15(2), 1994, pp. 147-153
Authors:
TILG H
TREHU E
SHAPIRO L
PAPE D
ATKINS MB
DINARELLO CA
MIER JW
Citation: H. Tilg et al., INDUCTION OF CIRCULATING SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTOR AND INTERLEUKIN-1 RECEPTOR ANTAGONIST FOLLOWING INTERLEUKIN-1-ALPHA INFUSION IN HUMANS, Cytokine, 6(2), 1994, pp. 215-219
Authors:
ATKINS MB
OBOYLE KR
SOSMAN JA
WEISS GR
MARGOLIN KA
ERNEST ML
KAPPLER K
MIER JW
SPARANO JA
FISHER RI
ECKARDT JR
PEREIRA C
ARONSON FR
Citation: Mb. Atkins et al., MULTIINSTITUTIONAL PHASE-II TRIAL OF INTENSIVE COMBINATION CHEMOIMMUNOTHERAPY FOR METASTATIC MELANOMA, Journal of clinical oncology, 12(8), 1994, pp. 1553-1560
Authors:
TILG H
SHAPIRO L
VANNIER E
POUTSIAKA DD
TREHU E
ATKINS MB
DINARELLO CA
MIER JW
Citation: H. Tilg et al., INDUCTION OF CIRCULATING ANTAGONISTS TO IL-1 AND TNF BY IL-2 ADMINISTRATION AND THEIR EFFECTS ON IL-2-INDUCED CYTOKINE PRODUCTION IN-VITRO, The Journal of immunology, 152(6), 1994, pp. 3189-3198
Authors:
TILG H
TREHU E
ATKINS MB
DINARELLO CA
MIER JW
Citation: H. Tilg et al., INTERLEUKIN-6 (IL-6) AS AN ANTIINFLAMMATORY CYTOKINE - INDUCTION OF CIRCULATING IL-1-RECEPTOR ANTAGONIST AND SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTOR-P55, Blood, 83(1), 1994, pp. 113-118
Authors:
TREHU EG
ISNER JM
MIER JW
KARP DD
ATKINS MB
Citation: Eg. Trehu et al., POSSIBLE MYOCARDIAL TOXICITY ASSOCIATED WITH INTERLEUKIN-4 THERAPY, Journal of immunotherapy with emphasis on tumor immunology, 14(4), 1993, pp. 348-351
Authors:
SPARANO JA
FISHER RI
SUNDERLAND M
MARGOLIN K
ERNEST ML
SZNOL M
ATKINS MB
DUTCHER JP
MICETICH KC
WEISS GR
DOROSHOW JH
ARONSON FR
RUBINSTEIN LV
MIER JW
Citation: Ja. Sparano et al., RANDOMIZED PHASE-III TRIAL OF TREATMENT WITH HIGH-DOSE INTERLEUKIN-2 EITHER ALONE OR IN COMBINATION WITH INTERFERON ALFA-2A IN PATIENTS WITH ADVANCED MELANOMA, Journal of clinical oncology, 11(10), 1993, pp. 1969-1977
Authors:
BRANDON EP
KOTIK AN
VACHINO G
SWACK JA
LIBBY P
JANICKA MW
ATKINS MB
MIER JW
Citation: Ep. Brandon et al., CULTURED HUMAN ENDOTHELIAL-CELLS EXPRESS THE 140-KD ISOFORM OF NEURALCELL-ADHESION MOLECULE (NCAM), International journal of immunopathology and pharmacology, 6(2), 1993, pp. 77-84
Authors:
TILG H
SHAPIRO L
ATKINS MB
DINARELLO CA
MIER JW
Citation: H. Tilg et al., INDUCTION OF CIRCULATING AND ERYTHROCYTE-BOUND IL-8 BY IL-2 IMMUNOTHERAPY AND SUPPRESSION OF ITS IN-VITRO PRODUCTION BY IL-1-RECEPTOR ANTAGONIST AND SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTOR (P75) CHIMERA, The Journal of immunology, 151(6), 1993, pp. 3299-3307